Henry Meds Reviews: Pricing and Cancellation Terms Compared (2026)

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Henry Meds holds a 4.4-star Trustpilot rating across approximately 13,000 reviews (captured September 4, 2026), a measurably stronger public rating than PlexusDx's 4.3 stars. That rating advantage comes alongside higher pricing: Henry charges $297/month for injectable semaglutide on a month-to-month plan versus PlexusDx's $189/month, and requires prepaid plan customers to pay remaining balances on early cancellation unless a healthcare provider determines medical necessity. Both providers include consultation, medication, supplies, and shipping in the subscription price; neither charges a separate membership fee. Henry's prepaid 12-month injectable semaglutide plan ($2,364 paid upfront, $197/month prepaid equivalent) narrows the gap but still runs $96/year higher than PlexusDx's 6-month prepaid rate ($1,788/year, $149/month prepaid equivalent). Henry offers oral tirzepatide and liraglutide options PlexusDx does not carry; PlexusDx offers injectable tirzepatide, which Henry does not. The central trade-off is transparent: Henry's slightly higher customer rating against PlexusDx's lower recurring cost and unrestricted month-to-month cancellation.

At a glance: Henry Meds vs PlexusDx

All pricing captured July 20, 2026, and September 4, 2026. Trustpilot ratings captured September 4, 2026.

Injectable semaglutide: normalized 12-month costs

Henry Meds' month-to-month injectable semaglutide subscription runs $297/month, yielding a 12-month cost of $3,564 (our calculation: 12 × $297). PlexusDx's month-to-month rate is $189/month, or $2,268 over 12 months (our calculation: 12 × $189) — a $1,296 annual difference in PlexusDx's favor.

Henry's 6-month prepaid plan requires $1,482 upfront ($247/month prepaid equivalent); over 12 months, two consecutive 6-month cycles total $2,964 (our calculation: 2 × $1,482). PlexusDx's 6-month prepaid plan is $894 upfront ($149/month prepaid equivalent), or $1,788 over 12 months (our calculation: 2 × $894) — a $1,176 annual difference.

Henry's 12-month prepaid plan is $2,364 paid in full ($197/month prepaid equivalent). PlexusDx does not offer a 12-month plan; its longest commitment is six months at $894 ($149/month prepaid equivalent, $1,788/year). Henry's 12-month prepaid option therefore runs $576 higher annually than PlexusDx's most competitive 6-month prepaid rate, even though Henry requires double the upfront commitment.

Oral semaglutide and other medications

Henry Meds offers two oral semaglutide formulations: sublingual tablets at $249/month month-to-month ($2,988/year, our calculation) and premium tablets or drops with an introductory rate of $179/month that reverts to a standard rate of $249/month. PlexusDx's oral semaglutide runs $289/month month-to-month ($3,468/year, our calculation). On oral semaglutide, Henry's sublingual option undercuts PlexusDx by $480 annually.

Henry offers oral tirzepatide as a 3-month prepaid supply at $891 ($297/month prepaid equivalent), or $3,564 over 12 months (our calculation: 4 × $891). No month-to-month option is available for oral tirzepatide. PlexusDx does not offer oral tirzepatide but does offer injectable tirzepatide at $289/month month-to-month ($3,468/year) or $249/month on a 6-month plan ($2,988/year, our calculation: 2 × $1,494). Henry does not offer injectable tirzepatide.

Henry also offers compounded liraglutide injection at $179/month month-to-month, with 6-month and 12-month prepaid options. PlexusDx does not offer liraglutide.

Cancellation and refund policies

Both providers allow month-to-month subscribers to cancel at any time. Henry Meds states cancellation can be initiated via the account portal, email (ask@henrymeds.com), or phone (909-787-2342); no notice period is specified beyond "anytime" (captured September 5, 2026).

For multi-month prepaid plans, Henry's terms state that customers "may be required to pay the remaining balance" unless they are "unable to continue for medical reasons as determined by [their] healthcare provider" (captured September 5, 2026). This means early exit from a 6-month or 12-month plan will typically obligate the customer to the full prepaid commitment unless a clinical exception applies.

PlexusDx offers month-to-month and prepaid 3-month or 6-month plans. Month-to-month plans carry no cancellation penalty. Prepaid plans represent a commitment period; the evidence does not document a partial-refund path for early exit.

Trustpilot ratings and review volume

Henry Meds holds a 4.4-star rating on Trustpilot with approximately 13,000 reviews (captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Henry's 0.2-star advantage and substantially larger review volume suggest a modest public-rating edge. The research capture did not include specific negative themes or individual complaint excerpts for Henry Meds, so this article cannot attribute service gaps or recurring issues beyond the aggregate rating.

The price-versus-rating trade-off is direct: Henry costs $108/month more on month-to-month injectable semaglutide ($297 vs $189) and holds a 0.2-star higher Trustpilot rating. Whether that incremental rating justifies the price premium depends on individual budget and risk tolerance.

Delivery, eligibility, and included services

Henry Meds ships medication within 8–10 business days after the provider visit, with subsequent refills every 45 days for injectables and every 90 days for oral tablets (captured September 5, 2026). California residents may experience longer fulfillment due to additional state testing requirements. Henry's age eligibility runs 18–70 (captured September 5, 2026).

Both providers include the initial consultation, ongoing provider access, medication, supplies, and shipping in the subscription price. Neither charges a separate membership fee. Both work with licensed 503A compounding pharmacies, and both require a licensed clinician to review the patient's intake and determine prescription appropriateness.

Choose Henry Meds if…

• You prioritize a slightly higher aggregate Trustpilot rating (4.4 stars vs 4.3 stars) and larger review volume.
• You want oral tirzepatide or liraglutide injection, which PlexusDx does not offer.
• You prefer oral semaglutide and want the lower-cost sublingual tablet ($249/month) or premium tablet/drop (introductory rate $179/month, standard rate $249/month) option versus PlexusDx's $289/month.
• You are comfortable with the prepaid-plan cancellation structure that may require balance payment unless a medical exception applies.

Choose PlexusDx if…

• You want injectable semaglutide and prioritize the lower recurring cost: $189/month month-to-month versus Henry's $297/month, or $149/month on a 6-month plan versus Henry's $197/month on a 12-month prepaid commitment.
• You want injectable tirzepatide, which Henry does not offer.
• You value unrestricted month-to-month flexibility without prepaid balance obligations on early exit.
• You prefer the shorter 6-month maximum commitment over Henry's 12-month option.
• The $1,296 annual month-to-month savings (injectable semaglutide) or $1,176 annual prepaid savings outweighs the 0.2-star Trustpilot gap in your decision calculus.

Methodology and freshness

All Henry Meds pricing was captured from the provider's legal programs page and verified across multiple source documents on July 20, 2026, and September 4, 2026. PlexusDx pricing was captured July 20, 2026. Trustpilot ratings and review volumes were captured September 4, 2026. Cancellation and refund policies were captured from Henry Meds' FAQ page September 5, 2026. No weight-loss outcome data, time-to-result claims, or specific customer complaint excerpts were available in the evidence set; this article therefore focuses on documented pricing, cancellation terms, aggregate ratings, and medication availability. All 12-month cost projections are our calculations, derived by multiplying monthly rates or summing prepaid cycles as labeled. Figures labeled "prepaid equivalent" divide the total prepaid amount by the number of months covered. Readers should confirm current pricing and terms at checkout, as telehealth providers may update rates or policies without notice.

Frequently Asked Questions

Can I cancel Henry Meds if the medication causes side effects?

Henry Meds allows cancellation anytime on month-to-month plans. For prepaid multi-month plans, you may be required to pay the remaining balance unless your healthcare provider determines you are unable to continue for medical reasons. Contact Henry's support (ask@henrymeds.com or 909-787-2342) to discuss your situation and any clinical documentation required for a medical exception.

Does PlexusDx offer a 12-month plan like Henry Meds?

No. PlexusDx's longest commitment is six months. Henry Meds offers a 12-month prepaid plan for injectable semaglutide at $2,364 upfront ($197/month prepaid equivalent), but PlexusDx's 6-month plan at $894 upfront ($149/month prepaid equivalent, $1,788/year) still costs $576 less annually than Henry's 12-month option.

Which provider has better customer reviews?

Henry Meds holds a 4.4-star Trustpilot rating across approximately 13,000 reviews (captured September 4, 2026). PlexusDx holds a 4.3-star rating with 79% five-star reviews and 83% four-star or higher. Henry's rating is 0.2 stars higher with substantially greater review volume, suggesting a modest public-rating advantage, though both providers hold aggregate ratings in the "good" range.

Does Henry Meds offer injectable tirzepatide?

No. Henry Meds offers oral tirzepatide as a 3-month prepaid supply at $891 ($297/month prepaid equivalent) but does not offer injectable tirzepatide. PlexusDx offers injectable tirzepatide at $289/month month-to-month or $249/month on a 6-month plan but does not offer oral tirzepatide.

Are the medications from Henry Meds and PlexusDx FDA-approved?

No. Both providers dispense compounded medications from 503A pharmacies. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient on a case-by-case basis.

Sources

• Henry Meds legal programs page (captured July 20, 2026, and September 4, 2026)
• Henry Meds FAQ and cancellation policy (captured September 5, 2026)
• PlexusDx pricing and service terms (captured July 20, 2026)
• Trustpilot: Henry Meds profile (captured September 4, 2026)
• Trustpilot: PlexusDx profile (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.